$SDGR
Schrodinger, Inc.

2022 Q2 Form 10-Q Financial Statement

#000156459022028010 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q4 2021 Q2
Revenue $38.47M $46.17M $29.78M
YoY Change 29.16% 39.78% 28.98%
Cost Of Revenue $21.34M $19.81M $17.80M
YoY Change 19.83% 41.09% 87.21%
Gross Profit $17.13M $26.36M $11.98M
YoY Change 43.02% 38.82% -11.8%
Gross Profit Margin 44.54% 57.1% 40.22%
Selling, General & Admin $29.48M $23.73M $21.23M
YoY Change 38.88% 29.96% 51.5%
% of Gross Profit 172.08% 90.02% 177.21%
Research & Development $31.12M $25.15M $21.09M
YoY Change 47.56% 45.18% 26.63%
% of Gross Profit 181.64% 95.39% 176.06%
Depreciation & Amortization $1.126M $652.0K $724.0K
YoY Change 55.52% -35.45% -17.73%
% of Gross Profit 6.57% 2.47% 6.04%
Operating Expenses $60.61M $48.88M $42.32M
YoY Change 43.2% 37.37% 37.99%
Operating Profit -$43.47M -$22.52M -$30.34M
YoY Change 43.28% 35.71% 77.57%
Interest Expense -$4.168M -$7.926M -$4.561M
YoY Change -8.62% -251.84% -134.84%
% of Operating Profit
Other Income/Expense, Net -$4.168M -$4.561M
YoY Change -8.62%
Pretax Income -$47.64M -$30.44M -$34.90M
YoY Change 36.5% 167.97% 772.58%
Income Tax $33.00K $274.0K $67.00K
% Of Pretax Income
Net Earnings -$47.69M -$30.71M -$34.64M
YoY Change 37.65% 175.7% 934.15%
Net Earnings / Revenue -123.96% -66.52% -116.32%
Basic Earnings Per Share -$0.67 -$0.49
Diluted Earnings Per Share -$0.67 -$433.0K -$0.49
COMMON SHARES
Basic Shares Outstanding 71.16M 70.58M
Diluted Shares Outstanding 71.16M 70.58M

Balance Sheet

Concept 2022 Q2 2021 Q4 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $509.6M $576.5M $613.6M
YoY Change -16.95% -10.3% 116.05%
Cash & Equivalents $127.3M $120.3M $120.7M
Short-Term Investments $382.2M $456.2M $495.9M
Other Short-Term Assets $15.56M $8.030M $10.29M
YoY Change 51.19% 63.88% 77.47%
Inventory
Prepaid Expenses $12.06M $5.030M
Receivables $18.77M $31.74M $25.95M
Other Receivables $963.0K $536.0K -$49.00K
Total Short-Term Assets $556.9M $625.1M $649.8M
YoY Change -14.3% -8.48% 111.66%
LONG-TERM ASSETS
Property, Plant & Equipment $11.52M $10.03M $14.45M
YoY Change -20.25% 95.04% -18.81%
Goodwill $4.791M $0.00
YoY Change
Intangibles $853.0K $0.00
YoY Change
Long-Term Investments $21.90M $43.17M $49.71M
YoY Change -55.94% -5.47% 119.0%
Other Assets $1.804M $2.851M $3.382M
YoY Change -46.66% 21.22% 60.89%
Total Long-Term Assets $131.0M $131.4M $67.55M
YoY Change 93.95% 107.67% 58.74%
TOTAL ASSETS
Total Short-Term Assets $556.9M $625.1M $649.8M
Total Long-Term Assets $131.0M $131.4M $67.55M
Total Assets $687.9M $756.5M $717.3M
YoY Change -4.11% 1.37% 105.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.263M $8.079M $5.960M
YoY Change -11.69% -3.8% 7.91%
Accrued Expenses $32.89M $27.76M $20.35M
YoY Change 61.61% 43.11% 41.31%
Deferred Revenue $55.37M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $85.59M $91.21M $70.38M
YoY Change 21.61% 24.6% 63.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000M $300.0K $41.19M
YoY Change -97.57% -54.13% 6764.17%
Total Long-Term Liabilities $1.000M $300.0K $41.19M
YoY Change -97.57% -54.13% 6764.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.59M $91.21M $70.38M
Total Long-Term Liabilities $1.000M $300.0K $41.19M
Total Liabilities $194.8M $199.4M $111.6M
YoY Change 74.58% 63.12% 108.94%
SHAREHOLDERS EQUITY
Retained Earnings -$312.1M -$230.0M
YoY Change 77.49%
Common Stock $807.8M $787.0M
YoY Change 4.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $493.1M $557.1M $605.8M
YoY Change
Total Liabilities & Shareholders Equity $687.9M $756.5M $717.3M
YoY Change -4.11% 1.37% 105.22%

Cashflow Statement

Concept 2022 Q2 2021 Q4 2021 Q2
OPERATING ACTIVITIES
Net Income -$47.69M -$30.71M -$34.64M
YoY Change 37.65% 175.7% 934.15%
Depreciation, Depletion And Amortization $1.126M $652.0K $724.0K
YoY Change 55.52% -35.45% -17.73%
Cash From Operating Activities -$24.66M -$19.74M -$29.37M
YoY Change -16.06% -145.25% 224.56%
INVESTING ACTIVITIES
Capital Expenditures -$1.974M -$957.0K -$2.917M
YoY Change -32.33% 7.53% 495.31%
Acquisitions
YoY Change
Other Investing Activities $36.30M -$21.13M $17.73M
YoY Change 104.72% -59.63% -173.57%
Cash From Investing Activities $34.32M -$22.09M $14.81M
YoY Change 131.7% -58.51% -160.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 396.0K 1.217M 1.633M
YoY Change -75.75% -14.3% -323.7%
NET CHANGE
Cash From Operating Activities -24.66M -19.74M -29.37M
Cash From Investing Activities 34.32M -22.09M 14.81M
Cash From Financing Activities 396.0K 1.217M 1.633M
Net Change In Cash 10.06M -40.61M -12.93M
YoY Change -177.84% 395.27% -62.39%
FREE CASH FLOW
Cash From Operating Activities -$24.66M -$19.74M -$29.37M
Capital Expenditures -$1.974M -$957.0K -$2.917M
Free Cash Flow -$22.68M -$18.78M -$26.46M
YoY Change -14.27% -142.2% 209.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493073000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38469000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62027061
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87132000
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29784000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
21335000
us-gaap Gross Profit
GrossProfit
45117000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
382246000
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
1540 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
108000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
30000
dei Entity Central Index Key
EntityCentralIndexKey
0001490978
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
124000
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
40000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
295-5800
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SDGR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127319000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
3500000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456212000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18767000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31744000
CY2022Q2 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
12978000
CY2021Q4 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
8807000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120267000
dei Entity File Number
EntityFileNumber
001-39206
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312078000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21092000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30342000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71161892
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70582062
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
17804000
CY2022Q2 us-gaap Gross Profit
GrossProfit
17134000
CY2021Q2 us-gaap Gross Profit
GrossProfit
11980000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31123000
us-gaap Cost Of Revenue
CostOfRevenue
42015000
CY2021Q4 us-gaap Liabilities
Liabilities
199402000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75384000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
300000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91211000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77827000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7317000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
18405000
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
21903000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
55368000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2042000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
30064000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Assets Current
AssetsCurrent
556872000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5030000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11524000
CY2022Q2 us-gaap Goodwill
Goodwill
4791000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
625060000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10025000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
43167000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2851000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
853000
CY2021Q4 us-gaap Assets
Assets
756487000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90133000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1804000
CY2022Q2 us-gaap Assets
Assets
687880000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8079000
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
16533000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
47440000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7180000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9174000
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
20105000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88112000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000
CY2022Q2 us-gaap Liabilities
Liabilities
194807000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11828000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
sdgr Noncash Revenue From Equity Investments
NoncashRevenueFromEquityInvestments
11000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62027061
CY2021Q4 us-gaap Minority Interest
MinorityInterest
14000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-651000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
756487000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61834515
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
786964000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
557071000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61834515
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
807827000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229952000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3403000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
493058000
CY2022Q2 us-gaap Minority Interest
MinorityInterest
15000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
687880000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58945000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7428000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5380000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14099000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15850000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44189000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
60607000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
42322000
us-gaap Operating Expenses
OperatingExpenses
117233000
us-gaap Operating Income Loss
OperatingIncomeLoss
-72116000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11828000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11828000
CY2022Q2 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-15700000
CY2021Q2 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-4918000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-21864000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47641000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34903000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82120000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4168000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4561000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10004000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-326000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-34970000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000
us-gaap Profit Loss
ProfitLoss
-82125000
us-gaap Net Income Loss
NetIncomeLoss
-82126000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-47674000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47686000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7016000
CY2021Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
338000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71161892
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70582062
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47686000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-34644000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-746000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48432000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34645000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-34451000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530670000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-746000
CY2022Q2 sdgr Increase In Operating Lease Right Of Use Asset
IncreaseInOperatingLeaseRightOfUseAsset
13621000
dei Entity Registrant Name
EntityRegistrantName
Schrodinger, Inc.
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M28D
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12062000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5263000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
85590000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61911000
us-gaap Cost Of Revenue
CostOfRevenue
33767000
us-gaap Gross Profit
GrossProfit
28144000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42540000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10619000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22056000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29239000
us-gaap Operating Expenses
OperatingExpenses
82398000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43473000
us-gaap Operating Income Loss
OperatingIncomeLoss
-54254000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19906000
us-gaap Profit Loss
ProfitLoss
-35493000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-296000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
357000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
777000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18902000
us-gaap Profit Loss
ProfitLoss
-82125000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35352000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
141000
us-gaap Profit Loss
ProfitLoss
-35493000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-820000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-34644000
us-gaap Net Income Loss
NetIncomeLoss
-34673000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71106470
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71106470
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70328254
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70328254
us-gaap Net Income Loss
NetIncomeLoss
-82126000
us-gaap Net Income Loss
NetIncomeLoss
-34673000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2752000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-241000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84878000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34914000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2006000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
908000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9134000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
396000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10427000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-47674000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493073000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
624019000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-240000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3656000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4366000
CY2021Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
498000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-523000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
631776000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1612000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-34970000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
605771000
us-gaap Profit Loss
ProfitLoss
-35493000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-21864000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19906000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2095000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1614000
us-gaap Share Based Compensation
ShareBasedCompensation
19561000
us-gaap Share Based Compensation
ShareBasedCompensation
11382000
sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
811000
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
-1719000
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
-2343000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-19000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
2000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13489000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10064000
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
4095000
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
925000
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-3140000
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-2663000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8719000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3914000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2938000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2489000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1872000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1460000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17887000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8030000
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
364000
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2816000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2860000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4074000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64378000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40293000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3670000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3427000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
600000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1700000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
11828000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
375000
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
15735000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6427000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
111215000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
222725000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
180710000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
164645000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
70626000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47097000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1304000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5268000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
25000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1304000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5293000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7552000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-82097000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123267000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202796000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130819000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120699000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
171000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
224000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
80000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
51000
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets Contingency Resolution
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsContingencyResolution
1513000
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
14767000
sdgr Noncash Or Part Noncash Acquisitions Of Lease Liabilities
NoncashOrPartNoncashAcquisitionsOfLeaseLiabilities
14767000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.34%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">e</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;font-style:normal;"/>Concentrations</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:3.34%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade receivables.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.34%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not require customers to provide collateral to support accounts receivable. If deemed necessary, credit reviews of significant new customers may be performed prior to extending credit. The determination of a customer’s ability to pay requires judgment, and failure to collect from a customer can adversely affect revenue, cash flows, and results of operations.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.34%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2022, two customers accounted for 19% and 19% of total accounts receivable, respectively. As of December 31, 2021, three customers accounted for 17%, 15%, and 11% of total accounts receivable, respectively. One customer accounted for 16% of total revenues during the three months ended June 30, 2022, and two customers accounted for 12% and 12% of total revenue during the six months ended June 30, 2022, respectively. One customer accounted for 13% and 11% of total revenues during the three and six months ended June 30, 2021, respectively.</p>
CY2022Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1
CY2022Q2 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
8458000
CY2021Q2 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
5732000
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
24040000
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
11519000
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12015000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8271000
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22303000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
40599000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14780000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
27676000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.70
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24617000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
1002000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
588000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
95000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
297000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
1100000
CY2022Q1 sdgr Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
4791000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
7873000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
209000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
235000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
444000
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
7429000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1100000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
533249000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
620927000
CY2021 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
2000000
CY2021 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-113000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1887000
CY2022Q1 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-128000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1759000
CY2022Q2 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
600000
CY2022Q2 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-294000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2065000
CY2022Q2 sdgr Lease Termination Fee Received Upon Early Termination Of Lease
LeaseTerminationFeeReceivedUponEarlyTerminationOfLease
295000
CY2022Q2 sdgr Fair Value Assets No Transfers Between Level Amount
FairValueAssetsNoTransfersBetweenLevelAmount
0
CY2021Q4 sdgr Fair Value Assets No Transfers Between Level Amount
FairValueAssetsNoTransfersBetweenLevelAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
sdgr Operating Lease Expiration Year
OperatingLeaseExpirationYear
2037
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P14Y
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
13621000
CY2022Q2 us-gaap Lease Cost
LeaseCost
0
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2830000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1417000
us-gaap Operating Lease Cost
OperatingLeaseCost
5290000
us-gaap Operating Lease Cost
OperatingLeaseCost
2887000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
752000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1518000
us-gaap Operating Lease Payments
OperatingLeasePayments
1301000
us-gaap Operating Lease Payments
OperatingLeasePayments
2914000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2052000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10590000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11292000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11016000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10588000
CY2022Q2 sdgr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
104525000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
150063000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
54771000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
95292000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7180000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88112000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
141000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2095000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10427000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7016000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19561000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11382000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0068
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47686000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47686000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-34644000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-34644000
us-gaap Net Income Loss
NetIncomeLoss
-82126000
us-gaap Net Income Loss
NetIncomeLoss
-82126000
us-gaap Net Income Loss
NetIncomeLoss
-34673000
us-gaap Net Income Loss
NetIncomeLoss
-34673000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71161892
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71161892
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70582062
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70582062
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71106470
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71106470
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70328254
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70328254
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38469000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29784000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87132000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61911000
CY2022Q2 us-gaap Gross Profit
GrossProfit
17134000
CY2021Q2 us-gaap Gross Profit
GrossProfit
11980000
us-gaap Gross Profit
GrossProfit
45117000
us-gaap Gross Profit
GrossProfit
28144000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31123000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21092000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58945000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42540000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7428000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5380000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14099000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10619000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22056000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15850000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44189000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29239000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11828000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11828000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000
CY2022Q2 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-15700000
CY2021Q2 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-4918000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-21864000
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19906000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-296000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
357000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
777000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
141000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-47674000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-34970000
us-gaap Profit Loss
ProfitLoss
-82125000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38469000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29784000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87132000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61911000

Files In Submission

Name View Source Status
0001564590-22-028010-index-headers.html Edgar Link pending
0001564590-22-028010-index.html Edgar Link pending
0001564590-22-028010.txt Edgar Link pending
0001564590-22-028010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g5mchgb5gxud000001.jpg Edgar Link pending
g5mchgb5gxud000007.jpg Edgar Link pending
g5mchgb5gxud000008.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdgr-10q_20220630.htm Edgar Link pending
sdgr-10q_20220630_htm.xml Edgar Link completed
sdgr-20220630.xsd Edgar Link pending
sdgr-20220630_cal.xml Edgar Link unprocessable
sdgr-20220630_def.xml Edgar Link unprocessable
sdgr-20220630_lab.xml Edgar Link unprocessable
sdgr-20220630_pre.xml Edgar Link unprocessable
sdgr-ex101_13.htm Edgar Link pending
sdgr-ex103_62.htm Edgar Link pending
sdgr-ex104_60.htm Edgar Link pending
sdgr-ex105_61.htm Edgar Link pending
sdgr-ex106_58.htm Edgar Link pending
sdgr-ex107_59.htm Edgar Link pending
sdgr-ex311_8.htm Edgar Link pending
sdgr-ex312_9.htm Edgar Link pending
sdgr-ex321_6.htm Edgar Link pending
sdgr-ex322_7.htm Edgar Link pending
Show.js Edgar Link pending